ImmunoGen Inc (NASDAQ:IMGN)

10.12
Delayed Data
As of Apr 17
 +0.04 / +0.40%
Today’s Change
5.34
Today|||52-Week Range
14.80
+65.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-58.3M-73.3M-72.8M-71.4M
 
 
 
 
 
Depreciation4.9M4.6M4.6M4.6M
 
 
 
 
 
Total Other Cash Flow4.3M9.4M12.4M29.2M
 
 
 
 
 
Funds From Operations-49.1M-59.3M-55.7M-37.5M
 
 
 
 
 
Funds From/For Other Operating Expenses-41.1M-25.0M4.6M16.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-8.0M-34.3M-60.3M-53.7M
 
 
 
 
 
 
InvestingDecrease In Investments1.2M0.000.000.00
 
 
Capital Expenditures-2.0M-2.9M-3.8M-8.2M
 
 
 
 
 
Other Investing - Uses0.00-60.0K0.00-1.0K
 
 
 
Other Investing - Sources168.0K0.0074.0K0.00
 
 
 
Net Cash Flow Investing-660.0K-3.0M-3.7M-8.2M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale90.7M7.0M98.0M9.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing90.7M7.0M98.0M9.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash82.1M-30.3M34.0M-52.7M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account